Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-31

Clinical Trial Update: Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on Probuphine for opioid dependence evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probuphine (buprenorphine implant)

Snippet

Sponsor: Titan Pharmaceuticals | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED